In vitro analysis of the activity of human monoamine oxidase type B (hMAOB), treated with the cyanotoxin anatoxin-a: supposed factor of neurodegenerative diseases


	Results from hMAOB activity, treated with anatoxin-a. * P < 0.05; P < 0.01; * P < 0.001 vs control (pure hMAOB).

Part of: Ilieva V, Kondeva-Burdina M, Georgieva T (2020) In vitro analysis of the activity of human monoamine oxidase type B (hMAOB), treated with the cyanotoxin anatoxin-a: supposed factor of neurodegenerative diseases. Pharmacia 67(2): 111-114. https://doi.org/10.3897/pharmacia.67.e50806